Concepedia

Timothy K. Erick

TK

Statistics

Publications

8

Citations

229

H-Index

8

Active since

2014

Affiliations

Harvard University(Current)

Brown University

Dana-Farber Cancer Institute

Dana-Farber Brigham Cancer Center

University of North Carolina at Charlotte

Timothy K. Erick is an author at Harvard University specializing in immunology, oncology, and medicine.

Publications per year

2014–2025

8

Publications

8

Inflammation-Induced Lactate Leads to Rapid Loss of Hepatic Tissue-Resident NK Cells

Garvin Dodard, Angela Tata, Timothy K. Erick et al. · Cell Reports · 2020 · 44 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Preclinical evaluation of an <sup>111</sup>In/<sup>225</sup>Ac theranostic targeting transformed MUC1 for triple negative breast cancer

Vanessa J. Kelly, Shu-ta Wu, Gottumukkala Vijay et al. · Theranostics · 2020 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

NFIL3 Expression Distinguishes Tissue-Resident NK Cells and Conventional NK-like Cells in the Mouse Submandibular Glands

Timothy K. Erick, Courtney Anderson, Emma C. Reilly et al. · The Journal of Immunology · 2016 · 34 citations · Full text

Life Sciences, Developmental Biology, Immunology +14

Role of Type I Interferon Receptor Signaling on NK Cell Development and Functions

Jean Guan, S. M. Shahjahan Miah, Zachary Wilson et al. · PLoS ONE · 2014 · 32 citations · Full text

Life Sciences, Cell Biology, Immunology +17

The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers

Karen S. Anderson, Timothy K. Erick, Meixuan Chen et al. · Breast Cancer Research and Treatment · 2022 · 23 citations · Full text

Medicine, Immunology, Oncology +16

1–5 of 8